|
|
|
Our team understands all stages of process development starting with cloning and extending to final product manufacture. Our broad capabilities include fermentation, purification, formulation and full analytical development. Our staff conducts stability studies and manufacture of preclinical and clinical batches under well-documented and well-controlled conditions. XOMA has exceptional analytical services, conducted in accordance with cGMP regulations, to comprehensively characterize your recombinant protein. XOMA’s pilot plant includes two trains of 130L and 500L bioreactors and associated purification suites. Formulation development of liquid product can also be performed. |
©XOMA 2008